Africa

Morocco

South Africa

Asia Pacific

Australia

China

Hong Kong SAR China

Japan

Korea

New Zealand

Singapore

Thailand

Europe

Austria

Belgium

Czech Republic

Denmark

Finland

France

Germany

Hungary

Ireland

Italy

Luxembourg

Netherlands

Norway

Poland

Portugal

Romania

Slovak Republic

Spain

Sweden

United Kingdom

Latin America

Argentina

Brazil

Chile

Mexico

Peru

Puerto Rico

Middle East

Bahrain

Oman

Qatar

UAE

North America

Canada

Puerto Rico

United States

OtherForMigration

Jean-Christophe Top

He/himLawyer

Emailjeanchristophe.top@dlapiper.com

Call+32 (0)2 500 1662

Brussels

About

Jean-Christophe is a life sciences & healthcare lawyer that assists his clients with a variety of legal and regulatory matters under both EU and Benelux law.

His main area of expertise includes the commercialization of complex and innovative treatments, such as cell & gene therapies (ATMPs), and the implementation of compliance systems & documentation, including those related to quality management, ISO standards and ethical conduct in the healthcare sector. He furthermore also advises on food and chemical matters.

In addition to his activities as...

Areas of FocusHealthcare Life Sciences Intellectual Property Data, Privacy and Cybersecurity Technology

Bar admissionsAdvocaat registered with the Nederlandse Orde van Advocaten bij de Balie te Brussel

EXPERIENCE

Assisted a European biotech company with identifying the requirements for the rollout of its Advanced Therapy Medicinal Product (ATMP) in several European countries, as well as the legal and regulatory considerations for the on-site manufacturing thereof.
Assisted a US pharmaceutical company with the rollout of its autologous Advanced Therapy Medicinal Product (ATMP) through the drafting and negotiation of contracts and documents with various European healthcare institutions and auth...

Assisted a European biotech company with identifying the requirements for the rollout of its Advanced Therapy Medicinal Product (ATMP) in several European countries, as well as the legal and regulatory considerations for the on-site manufacturing thereof.
Assisted a US pharmaceutical company with the rollout of its autologous Advanced Therapy Medicinal Product (ATMP) through the drafting and negotiation of contracts and documents with various European healthcare institutions and authorities.
Assisted a Japanese medical device company with the implementation of Regulation (EU) 2017/745 (MDR) and its Brexit transition, including reviewing its business setup and Quality Management System (QMS) documentation.
Assisted a Belgian governmental agency within the framework of the COVID-19 pandemic, including with the purchase and distribution of COVID-19 medicinal and medical device products, as well as with the implementation of various COVID-19 health safety measures.
Assisted a global pharmaceutical and medical device company with several medical equipment borderline cases.
Assisted a global medical device company with a large cross-border ethics compliance project, including the mapping of applicable ethics and (Sunshine Act) disclosure requirements, and with the drafting of internal SOPs.
Represented a global medical device company during inquiries surrounding alleged non-conformities by competent health authorities in Belgium and the UK.
Assisted a global medical device company with a product recall and withdrawal in Europe, including with the identification of appropriate Corrective and Preventive Actions (CAPA).
Assisted two Belgian hospitals within the framework of a potential merger, identifying the requirements for such merger and analysing the impact of the new collaboration on both organisations.
Assisted a Belgian biotech company with its correspondence with the Belgian and other European food authorities regarding the unlawful market entry of one of its competitors.
Assisted a European food packaging company with mapping the requirements and upcoming changes to the European and Belgian legislation on food contact materials.
Assisted on various due diligence assignments within the framework of life sciences financing rounds and M&As.

Education

KU Leuven, Credits, Biochemistry and Biotechnology, 2022

University of Liège, Master of Laws in EU Competition and IP Law, Summa cum laude, 2019

KU Leuven, Master of Laws, cum laude, 2018

University of Oslo, Erasmus+ exchange, 2017

Languages

Prior Experience

Before joining DLA Piper in 2024, Jean-Christophe worked as a regulatory lawyer in an international law firm and before that as a patent litigator in a boutique IP firm.

Additional News